trans-4,15,16,17-Tetrahydro-11-methyl-3H-cyclopenta(a)phe nanthrene-3,4-diol (145627-69-6)

Identification
Name:	trans-4,15,16,17-Tetrahydro-11-methyl-3H-cyclopenta(a)phe nanthrene-3,4-diol
CAS:	145627-69-6
Molecular Formula:	C₁₈H₁₈O₂
Molecular Weight:	266.3343
InChI:	InChI=1/C18H18O2/c1-10-9-11-3-2-4-12(11)13-5-6-15-14(17(10)13)7-8-16(19)18(15)20/h5-9,16,18-20H,2-4H2,1H3/t16-,18-/m1/s1
Molecular Structure:
Properties
Flash Point:	242.175°C
Boiling Point:	500.585°C at 760 mmHg
Density:	1.312g/cm³
Refractive index:	1.726
Flash Point:	242.175°C
Safety Data

Other Product

Dispiro[furan-2(3H),2'(13'H)-bisfuro[3'',2'':3',4']- cyclopenta[1',2':5,6]naphtho[1,2-b:1',2'-i]- phenazine-13',2''(3''H)-furan]-11',22'-diol,1',- 3'a,4,4',4'',4'a,4'b,5,5',5'',6',6'a,7',9',9'a,9'b,10',- 11',11'a,11'b,12',14'a,15',15'a,15'b,16',17',17'a,- 18',20',20'a,20'b,21',22',22'a,22'bhexatriacontahydro- 1',5,5,5'',5'',9'a,11'a,12',- 20'a,22'a-decamethyl-,(1'S,2R,2''S,3'aS,4'aR,- 4'bR,6'aS,9'aS,9'bS,11'R,11'aS,11'bR,12'S,- 14'aS,15'aR,15'bR,17'aS,20'aS,20'bS,22'R,22'aS,- 22'bR)-
Dispiro[furan-2(3H),2'(13'H)-bisfuro[3'',2'':3',4']- cyclopenta[1',2':5,6]naphtho[1,2-b:1',2'-i]- phenazine-13',2''-[2H]pyran]-5'',11',22'-triol,1',3'',3'a,4,4',4'',4'a,4'b,5,5',5'',6',6'',6'a,7',9',9'a,- 9'b,10',11',11'a,11'b,12',14'a,15'b,16',17',17'a,18',- 20',20'a,20'b,21',22',22'a,22'bhexatriacontahydro- 1',5,5,5'',9'a,11'a,12',20'a,- 22'a-nonamethyl-,(1'S,2R,2''R,3'aS,4'aR,4'bR,- 6''S,6'aS,9'aS,9'bS,11'R,11'aR,11'bR,12'S,14'aS,- 15'bR,17'aS,20'aS,20'bS,22'R,22'aS,22'bR)-
Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione)
15H-Cyclopenta[a]phenanthren-15-one,17-methyl-16-phenyl-
Dispiro[cyclopropane-1,6'(17'H)-cyclopropa[15,16]cyclopenta[a]phenanthrene-17',2''(5''H)-furan]-3',5''(2'H)-dione,1',3'',4'',7',8',9',10',11',12',13',14',15',16',20'-tetradecahydro-10',13'-dimethyl-,(2''S,8'R,9'S,10'R,13'S,14'R,15'S,16'S)-
1/C17H18OS/c1-4-11-7-5-8-12-13-9-6-10-14(17(2,3)18)16(13)19-15(11)12/h5-10,18H,4H2,1-3H
17-Norkaur-15-ene-9,11-diol,13-[[(4-bromobenzoyl)oxy]methyl]-, 11-(4-bromobenzoate), (8b,11b,13b)- (9CI)
(12H-11-OXA-17-THIA-15-AZA-CYCLOPENTA[A]PHENANTHREN-16-YL)-HYDRAZINE
1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
1/C11H9N5O/c1-17-6-2-3-8-9(4-6)16-11(14-8)7(5-12)10(13)15-16/h2-4,14H,1H3,(H2,13,15
17H-Cyclopenta[a]phenanthren-17-one,3,4,15,16-tetrahydro-3,4-dihydroxy-11-methyl-, trans- (9CI)
1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
Spiro[furan-2(3H),2'-[2H,21H]porphine],1',3',4',- 5',6',7',8',9',10',11',12',13',14',15',16',17',18',19',- 20',23'-eicosahydro-
3,6,9,13-Tetraoxa-16-azabicyclo[9.3.3]heptadeca-1(15),11(17)-diene-2,10-dione, 15-methyl-
(13S,17β)-12,13,16,17-Tetrahydro-17-hydroxy-3-methoxy-13-methyl-11H-cyclopenta[a]phenanthrene-15-carboxylic acid
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
2-[(8'R,9'S,10'S,13'S,14'S)-13'-methyl-1',2',4',7',8',9',11',12',13',14',15',16'-dodecahydro-10'H-dispiro[1,3-dioxolane-2,17'-cyclopenta[a]phenanthrene-3',2''-[1,3]dioxolan]-10'-yl]ethanamine acetate (1:1)
1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H